Investors in Capital

Ballpark Ventures is a boutique fund specializing in early-stage technology startup investments. With a focus on nurturing innovation and entrepreneurship, Ballpark Ventures provides strategic funding and support to promising startups. The firm's partners bring valuable experience as successful entrepreneurs themselves, offering insights and mentorship to portfolio companies. Ballpark Ventures aims to identify and invest in disruptive technologies and business models that have the potential for significant growth and impact. By leveraging their network and expertise, Ballpark Ventures strives to accelerate the growth trajectory of early-stage startups and maximize their long-term success.

Talis Capital invests on behalf of a community of cross-sector entrepreneurs, backing founders with unique visions for the future. Specializing in early-stage investments, Talis Capital seeks out innovative startups that challenge the status quo and drive technological and societal advancements. By providing both capital and strategic support, Talis Capital partners with visionary entrepreneurs to help them scale their businesses and realize their ambitions. Their diverse portfolio spans various industries, unified by a commitment to fostering transformative ideas and creating long-term value.

Esperante, a corporate venture capital firm affiliated with a global life science group, boasts leadership with deep operational expertise in the development, manufacturing, and global marketing of prescription pharmaceuticals and in vitro clinical diagnostic tests. Since its establishment in 2004, Esperante has strategically invested in 24 pharmaceutical and diagnostic companies across the US, UK, continental Europe, and Israel. Notably, the firm has achieved three successful exits: Thiakis to Wyeth/Pfizer, Pinnacle Biologics to Concordia, and Haemostatix to Ergomed. Currently, four portfolio companies are publicly listed in the US, Canada, and UK, with a focus on therapeutics in advanced clinical stages and diagnostics companies entering the European market. Esperante pursues initial investments of up to EUR 2,000,000 per venture in collaboration with other investors, aiming for exits through sales or liquidity events within a three-year timeframe.

Prime Ventures is a premier venture capital firm specializing in investing in European companies within the technology and related industries. Leveraging its substantial capital, extensive experience, and expansive network, Prime Ventures actively supports portfolio companies on their path to becoming global category leaders. The firm has a strong track record of investments across the Benelux countries, United Kingdom, France, Finland, and Sweden. With offices strategically located in The Netherlands and the UK, Prime Ventures operates as an independent partnership managing over 750 million euros in committed capital. By partnering closely with visionary entrepreneurs and providing strategic guidance, Prime Ventures catalyzes growth and innovation, shaping the future of technology across Europe.

TIIN Capital is a prominent venture capital firm based in the Netherlands, specializing in early-stage investments in innovative technology startups. Founded in 2000, TIIN Capital focuses on supporting entrepreneurs and companies that are developing disruptive technologies and scalable business models. The firm's investment strategy covers a wide range of sectors, including technology, life sciences, sustainability, and digital transformation. TIIN Capital typically invests in companies that demonstrate strong growth potential, innovative solutions, and a clear path to market leadership.

Digital Space Ventures is a smart money venture fund that invests in early-stage startups. Our focus is on companies that are driving innovation and transformation in the areas of Financial Services, Data/AI, Enterprise Software, and Decentralized Technologies. Backed by experienced investors with a wealth of knowledge and expertise, our investment approach is centred around the concept of “smart money,” which means that we actively partner with the founding entrepreneurs of our portfolio companies.

Mojo Capital manages the European Digital Opportunities Fund that integrates investments in European Venture Capital funds, secondaries, co-investments and direct investments in startups focused on digital opportunities. Managed by a team of experienced European venture capital investors.

XO Ventures is a venture capital investment firm based in the heart of Silicon Valley, specializing in early-stage technology startups. With a focus on disruptive innovations, XO Ventures provides strategic capital and mentorship to entrepreneurs across various sectors including AI, biotech, and fintech. Their team of experienced investors and advisors supports startups through the critical phases of growth, aiming to accelerate their development and market entry. XO Ventures is committed to fostering innovation and driving forward groundbreaking technologies that have the

Kathaka is a London-based single-family office that specializes in venture capital and philanthropy. With a dual focus on investing in innovative startups and supporting philanthropic initiatives, Kathaka aims to drive positive change and create lasting impact. They provide strategic capital and guidance to early-stage ventures while also dedicating resources to charitable causes, fostering a balanced approach to growth and giving back.

Founded in 2015, Coral Reef IO is an early-stage venture capital firm dedicated to financing technology-driven companies. Specializing in the venture capital landscape, Coral Reef IO supports startups and early-stage ventures that leverage technology to innovate and disrupt industries. The firm provides strategic capital and operational guidance to help its portfolio companies grow and achieve their full potential. Coral Reef IO aims to foster entrepreneurship and innovation by backing visionary founders and promising technologies that have the potential to make a significant impact in their respective markets.

Crane Venture Partners is a venture capital firm focused on investing in seed and early-stage companies in Europe, specializing in intelligent enterprise and deep tech sectors. The firm leverages its expertise and network to support startups developing cutting-edge technologies that redefine industries. Crane Venture Partners aims to accelerate the growth of its portfolio companies by providing strategic capital, operational guidance, and access to a robust network of industry partners. By focusing on intelligent enterprise and deep tech, Crane Venture Partners contributes to advancing innovation and driving transformation across various sectors in Europe.

M Ventures is the strategic corporate venture capital fund of Merck KGaA, Darmstadt, Germany. Established in 2009, it manages a fund of €600 million, investing in biotechnology and technology sectors. The fund focuses on healthcare drug development, life science tools, electronics, and frontier technology and sustainability. M Ventures aims to support visionary companies that develop innovative solutions for treating diseases, advancing scientific research, and addressing sustainability challenges. They take an active role in their portfolio companies, collaborating closely with entrepreneurs and co-investors.